4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-020266
Director sold 55,000 shares at an average $47.58 ($2,617,090)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Socks David A Director | 2021-03-10 | Sale | −2,425 | $48.32 | $117,167 | 1,433,520 | I |
| Socks David A Director | 2021-03-10 | Sale | −7,844 | $49.02 | $384,515 | 1,425,676 | I |
| Socks David A Director | 2021-03-10 | Sale | −1,802 | $49.93 | $89,974 | 1,423,874 | I |
| Socks David A Director | 2021-03-11 | Sale | −41,698 | $47.18 | $1,967,349 | 1,382,176 | I |
| Socks David A Director | 2021-03-11 | Sale | −731 | $47.54 | $34,749 | 1,381,445 | I |
| Socks David A Director | 2021-03-12 | Sale | −500 | $46.67 | $23,335 | 1,380,945 | I |
| Open-market sales · 55,000 sh · avg $47.58 · $2,617,090 | |||||||
Loading xslF345X03/doc4.xml…